Results 201 to 210 of about 653,631 (317)

N‐of‐1 trials in clinical research: Methodological foundations, statistical approaches and implementation challenges

British Journal of Clinical Pharmacology, EarlyView.
N‐of‐1 trials offer a unique and rigorous methodology for evaluating individualized treatment responses, particularly within the context of personalized medicine. This article provides a comprehensive explanation of the conceptual and methodological underpinnings of N‐of‐1 trials, with particular emphasis on statistical techniques and considerations ...
Marcos Clint Leal De Carvalho, Matheus de Matos Dourado Simões, Ubiratan Cardinalli Adler, Antonio Brazil Viana Junior, Caren Nádia Soares de Sousa, Lia Lira Olivier Sanders   +5 more
wiley   +1 more source

The doctor-patient relationship and informed consent process. [PDF]

Singapore Med J
Ang TL, Teo EK.
europepmc   +1 more source

Preventing and tackling bullying: advice for headteachers, staff and governing bodies [PDF]

, 2013

core  

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

British Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale, Clare Guilding, Jennifer Koenig, Michael Okorie, Reecha Sofat, Simon Maxwell   +5 more
wiley   +1 more source

Medical damage liability risk of medical AI: from the perspective of DeepSeek's large-scale deployment in Chinese hospitals. [PDF]

Front Public Health
Wang Y, Zhou Z.
europepmc   +1 more source

Making every contact count : a joint approach to preventing homelessness [PDF]

, 2012

core  

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Interdisciplinary recommendations for recurrent hyperkalaemia: insights from the GUARDIAN-HK European Steering Committee. [PDF]

Eur Heart J Cardiovasc Pharmacother
Savarese G, Izquierdo MJ, Bonanad C, Wong A, Schmitt R, Ferraro PM, Dentali F, Burton JO, Rosano G.   +8 more
europepmc   +1 more source

Code of practice for the assurance of academic quality and standards in higher education section 3: disabled students, draft for consultation - March 2009 [PDF]

, 2009

core